Mutant K-Ras was found in a subset of high-frequency methylated adenomas. They identified three classes of cancers and two classes of adenomas, high-frequency methylation and low-frequency methylation based on their DNA methylation patterns. sought to evaluate the effect of these alterations on the progression to colorectal cancer by conducting genome-wide array-based studies and comprehensive data analysis of aberrantly methylated loci in normal colon tissue (n=41), colon adenomas (n=42), and colorectal cancer (n=64). There is, however, considerable genetic and epigenetic heterogeneity resulting in different pathways to tumorigenesis. Figure 1 depicts key point mutations and its impact on morphologic changes of a benign polyp to colorectal cancer. There is a direct correlation between the size of the adenoma and its risk of developing future advanced adenomas or carcinoma with studies demonstrating this risk to be as high as 7.7%, 15.9%, and 19.3%, for adenomas 20mm, respectively.Ĭhromosomal instability and common point mutations occurring in colorectal cancer-related tumor suppressor genes (e.g., APC, P53) or tumor promoter genes (e.g., K-Ras) architect the progression from benign polyps to colorectal cancer. They are indolent in nature, typically growing slowly over the span of a decade or more. Unfortunately, the “miss rate” of colonoscopy for colorectal cancer and adenomas larger than 1 cm has been reported to be as high as 6% and 17%, respectively.Īdenomas and hamartomatous polyps, later discussed in depth, are polyps that carry malignant potential. To date, colonoscopy remains the cornerstone in colorectal cancer prevention. Subsequent long term data has validated the importance of colonoscopy and colonoscopic polypectomy in the prevention of colorectal cancer-related deaths. were among the first to demonstrate that colorectal adenomas have the potential to progress to colorectal adenocarcinoma, thus stressing the importance of colonoscopic polypectomy in colorectal cancer prevention. The vast majority of colorectal cancers stem from benign polyps arising from the mucosal layer. Globally, colorectal cancer is the fourth leading cause of cancer-related death accounting for approximately 700,000 deaths in 2012. It is estimated that in 2014, 71,830 men and 65,000 women were diagnosed with colorectal cancer with approximately 50,000 mortalities (26,270 men and 24,040 women) as a result of the disease. Polyps and potential progression to colorectal cancerĬolorectal cancer is the third most common cancer among men and women, and the third leading cause of cancer-related death in the United States.
0 Comments
Leave a Reply. |